US EditionPublished • loading... • Updated
Madrigal Pharmaceuticals relocating within West Conshohocken
Summary by MoreThanTheCurve
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Madrigal Pharmaceuticals relocating within West Conshohocken
The Philadelphia Business Journal reported on December 8th that West Conshohocken-based Madrigal Pharmaceuticals is relocating its headquarters to a larger space in West Conshohocken. Madrigal has made its home at Four Tower Bridge and is moving to the nearby Keystone Development + Investment’s 1K1 building. Madrigal is widely recognized for its research and obtaining the first U.S. Food and Drug Administration-approved treatment for MASH, a ser…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
